• Data Analysis
    Credits: Institut Pasteur
  • Study of alterations responsible for the transformation of a cell into a tumor cell.
    Credits: Institut Curie / Benoit Rajau
  • Analysis of a Tumor Genome
    Credits: Institut Curie / Benoît Rajau
  • Realistic Immersion in an Artificial Urban Area
    Credits: The Institut de la Vision
  • Stereotaxy Core Facility
    Credits: ICM
  • Research and Innovation in the Lymphoma Field
    Credits: LYSARC


February 9, 10, 2016
MIT Media Lab, 75 Amherst St, Cambridge, MA



The topic of the 2016 edition is “Precision Medicine & New Technologies: Transforming Clinical Research”. This conference is organized by the Office for Science & Technology of the Embassy of France in the United States in collaboration with MIT and the Global Care Initiative, a consortium of 5 non-profit French research Carnot Institutes.


About FAID 

FAID is an annual Franco-American event which brings together scientists, companies, entrepreneurs and investors. It is a high-level event in the Boston area where researchers and companies have the opportunity to exchange views on a specific technological issue, start co-operative activities and develop business transactions with a transatlantic perspective. The goal of the program is to facilitate the development of innovation ties between France and America.



The Office for Science and Technology (OST), a team of 24 staff members including professors, senior researchers and engineers located in the Embassy (Washington, DC) and 6 consular offices (Atlanta - Boston - Chicago - Houston - Los Angeles - San Francisco) is dedicated to bilateral FR-US collaborations in Science and Technology.


GLOBAL CARE Initiative is an outstanding consortium of 5 non- profit French research Carnot institutes dedicated to human health. The consortium operates as a one-stop-shop for life science companies and research organizations that seek R&D collaboration from basic research to the late clinical phases. The consortium has extensive experience of partnerships with major pharmaceutical, biotech and MedTech companies.